Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury

Hypertension

Volumn 39, Issue 2 II, 2002, Pages 685-689

  Park, Joon Keun ^a   Fiebeler, Anette ^a   Muller, Dominik N ^a   Mervaala, Eero M A ^a   Dechend, Ralf ^a   Abou Rebyeh, Faikah ^a   Luft, Friedrich C ^a   Haller, Hermann ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiotensin II; Calcium antagonists; Cell adhesion molecules; Nitric oxide synthase; Transcription

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LACIDIPINE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; BLOOD VESSEL INJURY; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME REPRESSION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; TRANSGENIC ANIMAL;

ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; CELL ADHESION MOLECULES; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR DISEASES;

EID: 0036176481     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy0202.103482     Document Type: Conference Paper

References (42)

1. Calcium antagonists and renal disease
2. Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis
3. Angiotensin II and calcium blockers prevent glomerular phenotypic changes in remnant kidney model
4. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats
5. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats
6. Novel mode of action of the calcium antagonist mibefradil (Ro 40-5967): Potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium
7. Small artery remodeling in hypertension: Can it be corrected?
8. Calcium channels and their involvement in cardiovascular disease
9. Chronic administration of nicardipine attenuates myocardial stunning in isolated rabbit hearts
10. Inhibitory effect of calcium channel blockers on human mesangial cell growth: Evidence for actions independent of L-type Ca2+ channels
11. Manidipine regulates the transcription of cytokine genes
12. The effect of nifedipine on lipid and monocyte infiltration of the subendothelial space
13. Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells
14. Lipophilic calcium antagonists in antiatherosclerotic therapy
15. High glucose concentrations increase endothelial cell permeability via activation of protein Kinase C alpha
16. Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells
17. Nifedipine inhibits activation transcription factor NF-κB
18. The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells
19. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells
20. High human renin hypertension in transgenic rats
21. Hypertension-induced end-organ damage: A new transgenic approach to an old problem
22. Blood pressure-independent effects in rats with human renin and angiotensinogen genes
23. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation
24. Antisense oligodesoxynucleotide strategies in renal and cardiovascular disease
25. Leukocyte adhesion molecules: Potential targets for therapeutic intervention in kidney diseases
26. Ischemia increases neutrophil retention and worsens acute renal failure: Role of oxygen metabolites and ICAM I
27. Direct antiatherogenic activity of isradipine and lacidipine on neointimal lesions induced by perivascular manipulation in rabbits
28. The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: Is calcium entry involved?
29. Modulation of adhesion molecule expression on endothelial cells by verapamil and other Ca++ channel blockers
30. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells
31. Endothelial function. General considerations
32. Macrophages in acute glomerular inflammation
33. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions
34. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: Long-term trial in renal transplantation patients
35. Inhibition of nitric oxide synthase as a potential therapeutic target
36. The role of L-arginine in hypertension and nephrotoxicity
37. Nitric oxide in renal health and disease
38. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells
39. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective
40. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis
41. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
42. D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding